APOE and Alzheimer disease: Recent data demonstrate that the risk for developing AD-dementia, as conferred by APOE-e4 carrier status, is closely linked to cerebral iron-burden, implicating potential benefit of therapeutic strategies aimed at lowering brain iron in this patient population10, 11.